Psychological Therapies for Schizophrenia and Other Primary Psychotic Disorders: Toward Precision, Personalization, and Real-World Impact

For many decades, psychological therapies were largely withheld from people with schizophrenia and other primary psychotic disorders (SPD). This was due, to a predominantly biological view of these conditions and concerns that addressing psychotic symptoms through psychological methods could harm patients by excaberating psychosis. Since the 1950s, however, psychological treatment approaches have evolved considerably, becoming evidence-based and now recommended by best practice guidelines for individuals with SPD. Nevertheless, there is a need for continued research to improve therapeutic outcomes for this population. This editorial introduces the themed issue "Psychological Therapies for Schizophrenia and Other Primary Psychotic Disorders: Toward Precision, Personalization, and Real-World Impact." The issue brings together innovative work at the intersection of translational science, personalized care, and ecological validity. The contributions highlight advances in mechanism-based interventions, understanding individual trajectories and treatment responses, and the integration of daily-life assessment and intervention through digital and mobile technologies. Collectively, this themed issue illustrates the energy and creativity with which the field is addressing the evolving needs of individuals with SPD. However, unresolved challenges remain. These efforts include the broad and accessible implementation of evidence-based approaches, as well as the active involvement of individuals with lived experience of psychosis in the development, evaluation, and implementation of new interventions.

Authors

Institutions

Publication Details

Journal
Schizophrenia Bulletin
Published
2025-11-12
DOI
https://doi.org/10.1093/schbul/sbaf216
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychological Therapies for Schizophrenia and Other Primary Psychotic Disorders: Toward Precision, Personalization, and Real-World Impact

Clementine Edwards, Matthias Pillny, Kerem Böge
Schizophrenia Bulletin
Schizophrenia research and treatment
article

Psychological Therapies for Schizophrenia and Other Primary Psychotic Disorders: Toward Precision, Personalization, and Real-World Impact

Clementine Edwards, Matthias Pillny, Kerem Böge
article en

Abstract

For many decades, psychological therapies were largely withheld from people with schizophrenia and other primary psychotic disorders (SPD). This was due, to a predominantly biological view of these conditions and concerns that addressing psychotic symptoms through psychological methods could harm patients by excaberating psychosis. Since the 1950s, however, psychological treatment approaches have evolved considerably, becoming evidence-based and now recommended by best practice guidelines for individuals with SPD. Nevertheless, there is a need for continued research to improve therapeutic outcomes for this population. This editorial introduces the themed issue "Psychological Therapies for Schizophrenia and Other Primary Psychotic Disorders: Toward Precision, Personalization, and Real-World Impact." The issue brings together innovative work at the intersection of translational science, personalized care, and ecological validity. The contributions highlight advances in mechanism-based interventions, understanding individual trajectories and treatment responses, and the integration of daily-life assessment and intervention through digital and mobile technologies. Collectively, this themed issue illustrates the energy and creativity with which the field is addressing the evolving needs of individuals with SPD. However, unresolved challenges remain. These efforts include the broad and accessible implementation of evidence-based approaches, as well as the active involvement of individuals with lived experience of psychosis in the development, evaluation, and implementation of new interventions.

Schizophrenia BulletinVol. 52(1)
Universität Hamburg (DE), King's College London (GB), South London and Maudsley NHS Foundation Trust (GB), University of California San Diego (US), Maudsley Hospital (GB), German Centre for Cardiovascular Research (DE), Hamburg Institut (Germany) (DE), Medizinische Hochschule Brandenburg Theodor Fontane (DE), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 53%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.